119 related articles for article (PubMed ID: 29911936)
21. Protein kinase D-dependent CXCR4 down-regulation upon BCR triggering is linked to lymphadenopathy in chronic lymphocytic leukaemia.
Saint-Georges S; Quettier M; Bouyaba M; Le Coquil S; Laurienté V; Guittat L; Lévy V; Ajchenbaum-Cymbalista F; Varin-Blank N; Le Roy C; Ledoux D
Oncotarget; 2016 Jul; 7(27):41031-41046. PubMed ID: 27127886
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies.
Peng SB; Zhang X; Paul D; Kays LM; Ye M; Vaillancourt P; Dowless M; Stancato LF; Stewart J; Uhlik MT; Long H; Chu S; Obungu VH
PLoS One; 2016; 11(3):e0150585. PubMed ID: 26954567
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
[TBL] [Abstract][Full Text] [Related]
24. Recognition and reactivity in the binding between Raf kinase inhibitor protein and its small-molecule inhibitor locostatin.
Rudnitskaya AN; Eddy NA; Fenteany G; Gascón JA
J Phys Chem B; 2012 Aug; 116(34):10176-81. PubMed ID: 22861375
[TBL] [Abstract][Full Text] [Related]
25. Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.
O'Hayre M; Salanga CL; Kipps TJ; Messmer D; Dorrestein PC; Handel TM
PLoS One; 2010 Jul; 5(7):e11716. PubMed ID: 20661426
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells.
Göckeritz E; Kerwien S; Baumann M; Wigger M; Vondey V; Neumann L; Landwehr T; Wendtner CM; Klein C; Liu N; Hallek M; Frenzel LP; Krause G
Int J Cancer; 2015 Nov; 137(9):2234-42. PubMed ID: 25912635
[TBL] [Abstract][Full Text] [Related]
27. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis, down-regulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells.
Stamatopoulos B; Meuleman N; De Bruyn C; Delforge A; Bron D; Lagneaux L
Haematologica; 2010 Jul; 95(7):1136-43. PubMed ID: 20145270
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
[TBL] [Abstract][Full Text] [Related]
29. BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia.
Chen SS; Chang BY; Chang S; Tong T; Ham S; Sherry B; Burger JA; Rai KR; Chiorazzi N
Leukemia; 2016 Apr; 30(4):833-43. PubMed ID: 26582643
[TBL] [Abstract][Full Text] [Related]
30. The dual inhibitor of the phosphoinositol-3 and PIM kinases, IBL-202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironment.
Crassini K; Shen Y; O'Dwyer M; O'Neill M; Christopherson R; Mulligan S; Best OG
Br J Haematol; 2018 Sep; 182(5):654-669. PubMed ID: 29978459
[TBL] [Abstract][Full Text] [Related]
31. FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemia.
Seda V; Vojackova E; Ondrisova L; Kostalova L; Sharma S; Loja T; Mladonicka Pavlasova G; Zicha D; Kudlickova Peskova M; Krivanek J; Liskova K; Kren L; Benes V; Musilova Litzmanova K; Borsky M; Oppelt J; Verner J; Pospisilova S; Brychtova Y; Panovska A; Tan Z; Zhang S; Doubek M; Amruz Cerna K; Mayer J; Mraz M
Blood; 2021 Sep; 138(9):758-772. PubMed ID: 33786575
[TBL] [Abstract][Full Text] [Related]
32. The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart.
Abd Alla J; Quitterer U
Cells; 2022 Feb; 11(4):. PubMed ID: 35203304
[TBL] [Abstract][Full Text] [Related]
33. Salvianolic acid B inhibits SDF-1α-stimulated cell proliferation and migration of vascular smooth muscle cells by suppressing CXCR4 receptor.
Pan CH; Chen CW; Sheu MJ; Wu CH
Vascul Pharmacol; 2012; 56(1-2):98-105. PubMed ID: 22166584
[TBL] [Abstract][Full Text] [Related]
34. Targeting inhibitor of apoptosis proteins by Smac mimetic elicits cell death in poor prognostic subgroups of chronic lymphocytic leukemia.
Opel D; Schnaiter A; Dodier D; Jovanovic M; Gerhardinger A; Idler I; Mertens D; Bullinger L; Stilgenbauer S; Fulda S
Int J Cancer; 2015 Dec; 137(12):2959-70. PubMed ID: 26096065
[TBL] [Abstract][Full Text] [Related]
35. Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Risnik D; Colado A; Podaza E; Almejún MB; Elías EE; Bezares RF; Fernández-Grecco H; Seija N; Oppezzo P; Borge M; Gamberale R; Giordano M
Cancer Immunol Immunother; 2020 May; 69(5):813-824. PubMed ID: 32055920
[TBL] [Abstract][Full Text] [Related]
36. Locostatin Disrupts Association of Raf Kinase Inhibitor Protein With Binding Proteins by Modifying a Conserved Histidine Residue in the Ligand-Binding Pocket.
Beshir AB; Argueta CE; Menikarachchi LC; Gascón JA; Fenteany G
For Immunopathol Dis Therap; 2011; 2(1):47-58. PubMed ID: 21709760
[TBL] [Abstract][Full Text] [Related]
37. Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression.
Huang Q; Bai F; Nie J; Lu S; Lu C; Zhu X; Zhuo L; Lin X
Int Immunopharmacol; 2017 Jan; 42():130-138. PubMed ID: 27912149
[TBL] [Abstract][Full Text] [Related]
38. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
Kim SO; Kim MR
Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
[TBL] [Abstract][Full Text] [Related]
39. Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells.
Peng SB; Peek V; Zhai Y; Paul DC; Lou Q; Xia X; Eessalu T; Kohn W; Tang S
Mol Cancer Res; 2005 Apr; 3(4):227-36. PubMed ID: 15831676
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.
Vlad A; Deglesne PA; Letestu R; Saint-Georges S; Chevallier N; Baran-Marszak F; Varin-Blank N; Ajchenbaum-Cymbalista F; Ledoux D
Cancer Res; 2009 Aug; 69(16):6387-95. PubMed ID: 19654311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
